BIOMAT Database Logo BIOMAT Database Logo

Plasmapheresis to treat human T lymphotropic virus type I-associated myelopathy. 1990

H Matsuo, and T Nakamura, and K Shibayama, and M Motomura, and K Nagasato, and G Takeo, and M Tsujihata, and S Nagataki
First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007937 Leukapheresis The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor. Leukocytapheresis,Leukopheresis,Lymphapheresis,Lymphocytapheresis,Leukocytopheresis,Lymphocytopheresis,Lymphopheresis,Leukaphereses,Leukocytaphereses,Leukocytophereses,Leukophereses,Lymphaphereses,Lymphocytaphereses,Lymphocytophereses,Lymphophereses
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females

Related Publications

H Matsuo, and T Nakamura, and K Shibayama, and M Motomura, and K Nagasato, and G Takeo, and M Tsujihata, and S Nagataki
Polyarthritis in human T lymphotropic virus type I-associated myelopathy.
October 1989, Arthritis and rheumatism,
H Matsuo, and T Nakamura, and K Shibayama, and M Motomura, and K Nagasato, and G Takeo, and M Tsujihata, and S Nagataki
Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I).
December 1992, Annals of internal medicine,
H Matsuo, and T Nakamura, and K Shibayama, and M Motomura, and K Nagasato, and G Takeo, and M Tsujihata, and S Nagataki
Spinal anesthesia in human T lymphotropic virus type I-associated myelopathy.
June 2001, Anesthesia and analgesia,
H Matsuo, and T Nakamura, and K Shibayama, and M Motomura, and K Nagasato, and G Takeo, and M Tsujihata, and S Nagataki
Retinal vasculitis in human T-lymphotropic virus type I associated myelopathy.
October 1989, The British journal of ophthalmology,
H Matsuo, and T Nakamura, and K Shibayama, and M Motomura, and K Nagasato, and G Takeo, and M Tsujihata, and S Nagataki
Human T-lymphotropic virus type I-associated myelopathy. A case report.
December 1991, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
H Matsuo, and T Nakamura, and K Shibayama, and M Motomura, and K Nagasato, and G Takeo, and M Tsujihata, and S Nagataki
Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy.
June 2001, Current opinion in neurology,
H Matsuo, and T Nakamura, and K Shibayama, and M Motomura, and K Nagasato, and G Takeo, and M Tsujihata, and S Nagataki
Mechanisms of human T-cell lymphotropic virus type I viral-associated myelopathy.
August 1994, Annals of neurology,
H Matsuo, and T Nakamura, and K Shibayama, and M Motomura, and K Nagasato, and G Takeo, and M Tsujihata, and S Nagataki
An autopsy case of human T-lymphotropic virus type I-associated myelopathy.
August 1988, Human pathology,
H Matsuo, and T Nakamura, and K Shibayama, and M Motomura, and K Nagasato, and G Takeo, and M Tsujihata, and S Nagataki
Human T-lymphotropic virus type I-associated myelopathy presenting as spinocerebellar syndrome.
April 1989, Annals of neurology,
H Matsuo, and T Nakamura, and K Shibayama, and M Motomura, and K Nagasato, and G Takeo, and M Tsujihata, and S Nagataki
Electroencephalographic abnormalities in human T-cell lymphotropic virus type I-associated myelopathy.
May 1989, Archives of neurology,
Copied contents to your clipboard!